India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials | Read
PUBLISHED ON: December 11, 2020 | Duration: 0 min, 24 sec
A vaccine being developed by the Pune-based Gennova has become India's first homemade mRNA candidate to get permission for human clinical trial, the government said today. The mRNA vaccines do not use the conventional model to produce immune response.
